Last10K.com

Redhill Biopharma Ltd. (RDHL) SEC Filing 20-F Annual Report for the fiscal year ending Friday, December 31, 2021

Redhill Biopharma Ltd.

CIK: 1553846 Ticker: RDHL

View differences made from one year to another to evaluate Redhill Biopharma Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Redhill Biopharma Ltd..

Continue

Assess how Redhill Biopharma Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Redhill Biopharma Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Comprehensive Loss
Consolidated Statements Of Financial Position
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (Details)
Accrued Expenses And Other Current Liabilities (Tables)
Allowance For Deductions From Revenues
Allowance For Deductions From Revenues (Details)
Allowance For Deductions From Revenues (Tables)
Borrowing
Borrowing (Details)
Borrowing (Tables)
Borrowing - Reconciliation Of Liabilities Arising From Financing Activities (Details)
Cash And Cash Equivalents
Cash And Cash Equivalents (Details)
Cash And Cash Equivalents (Tables)
Commitments
Commitments - Agreements To Purchase Intellectual Property (Details)
Commitments - Dsi Agreement (Details)
Commitments - Movantik Acquisition (Details)
Critical Accounting Estimates And Judgments
Critical Accounting Estimates And Judgments (Details)
Events Subsequent To December 31, 2021
Events Subsequent To December 31, 2021 (Details)
Financial Assets At Fair Value Through Profit Or Loss
Financial Assets At Fair Value Through Profit Or Loss (Details)
Financial Expenses (Income), Net
Financial Expenses (Income), Net (Details)
Financial Expenses (Income), Net (Tables)
Financial Instruments And Financial Risk Management
Financial Instruments And Financial Risk Management (Details)
Financial Instruments And Financial Risk Management (Tables)
Financial Instruments And Financial Risk Management - By Contractual Maturities (Details)
Fixed Assets
Fixed Assets (Details)
Fixed Assets (Tables)
General
General And Administrative Expenses
General And Administrative Expenses (Details)
General And Administrative Expenses (Tables)
Income Tax
Income Tax (Details)
Intangible Assets
Intangible Assets (Tables)
Intangible Assets - Changes In Assets (Details)
Intangible Assets - Narrative (Details)
Inventory
Inventory (Details)
Inventory (Tables)
Leases
Leases (Tables)
Leases - Amounts Recognized (Details)
Liability For Employee Rights Upon Retirement
Liability For Employee Rights Upon Retirement (Details)
Loss Per Ordinary Share
Loss Per Ordinary Share (Tables)
Loss Per Ordinary Share - Basic (Details)
Net Revenues
Net Revenues (Details)
Net Revenues (Tables)
Prepaid Expenses And Other Receivables
Prepaid Expenses And Other Receivables (Details)
Prepaid Expenses And Other Receivables (Tables)
Related Parties
Related Parties (Tables)
Related Parties - Balances With Related Parties (Details)
Related Parties - Key Management Compensation (Details)
Research And Development Expenses
Research And Development Expenses (Details)
Research And Development Expenses (Tables)
Segment Information
Segment Information (Details)
Segment Information (Tables)
Segment Information - Major Customers And Segment Assets (Details)
Selling And Marketing Expenses
Selling And Marketing Expenses (Details)
Selling And Marketing Expenses (Tables)
Share Capital
Share Capital (Details)
Share Capital (Tables)
Share-Based Payments
Share-Based Payments (Details)
Share-Based Payments (Tables)
Share-Based Payments - Expenses Recognized In Profit Or Loss (Details)
Share-Based Payments - Information About Exercise Price And Remaining Useful Life Of Outstanding Options (Details)
Share-Based Payments - Number Of Options And Weighted Averages Of Exercise Prices (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Ticker: RDHL
CIK: 1553846
Form Type: 20-F Annual Report
Accession Number: 0001558370-22-003806
Submitted to the SEC: Thu Mar 17 2022 8:11:29 AM EST
Accepted by the SEC: Thu Mar 17 2022
Period: Friday, December 31, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rdhl/0001558370-22-003806.htm